AstraZenca Pharma India

AstraZenca Pharma India

ASTRAZEN

 ₹ 6,535.05
- ₹ 11.60
0.18%
Healthcare
 ₹ 0.00
(%)1D
Updated: 06 Dec 2024, 03:31:19 pm IST
Stock Score
Open Price
 ₹ 6,642.95
Prev. Close
 ₹ 6,546.65
 ₹ 6,477.92
Day Low
 ₹ 6,657.79
Day High

 ₹ 4,799.82
52 Week Low
 ₹ 8,673.82
52 Week High

Quick Bite

Price To Earnings Ratio

101.16

Sector PE

71.67

PB Ratio

23.06

Sector PB

9.22

EPS

64.60

Dividend Yield

0.45

Today's Volume

6.294 K

5 Day Avg. Volume

14.208 K

PEG Ratio

1.61

Market Cap.

₹ 16,410.00 Cr.

Returns Comparison

TimeASTRAZENVSIndustry
1 Day-0.18%-1.57%
1 Week0.62%-0.71%
1 Month-12.58%-0.67%
6 Months-1.21%19.22%
1 Year31.16%40.41%

StockGro Trade Views 👍

StockGro Trade Views 👍

Technical Trend

Bearish
academy home
Bearish
Neutral
Bullish

Pivot Levels

R3 ₹ 6,687.66
R2 ₹ 6,634.28
R1 ₹ 6,584.67
RESISTANCE
 ₹ 6,531.29
SUPPORT
S1 ₹ 6,481.68
S2 ₹ 6,428.30
S3 ₹ 6,378.69

Updated: 22 Jul 2024,09:18:33 am IST

Moving Averages

Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
5
Buy
1
Period (Days)SMAIndication
106475.9Bullish
206622Bearish
306842.52Bearish
507093.7Bearish
1007014.37Bearish
2006630.2Bearish

Updated: 06 Dec 2024, 03:14:58 pm IST

Analyst Rankings 👍

Analyst Rankings 👍

Shareholding Updates

PromotersPublicDIIFIIOthers
75%
Promoters
Sep 2024
Promoters  75%
FII  2.9%
DII  5.1%
Public  17.01%
Others  0.01%

Mutual Fund Ownership 👍

Mutual Fund Ownership 👍

Cash Flow

AnnualFY 2024FY 2023FY 2022
Operating Activities27.8758.29100.80
Investing Activities21.7418.114.74
Financing Activities-44.38-24.48-9.46
Net Cash Flow5.2351.9296.08

All Figures in ₹ Cr., unless mentioned otherwise

Ratios

Return on Equity (%)

Income Statement

All Figures in ₹ Cr., unless mentioned otherwise

Balance Sheet

All Figures in ₹ Cr., unless mentioned otherwise

Peer Comparison

Name1D (%)1W (%)1M (%)6M (%)1Y (%)
AstraZenca Pharma India-0.180.62-12.58-1.2131.16
Advanced Enzyme Tech-0.46-1.07-24.783.6114.87
Alembic-1.433.50.721.941.94
Aster DM Healthcare0.6-1.4111.4440.6313.9
Divi's Laboratories0.47-0.396.1128.4860.6
Returns as on 06 Dec, 2024

About AstraZenca Pharma India

AstraZeneca Pharma India Limited is an India-based biopharmaceutical company. Its therapeutic areas include cardiovascular, renal and metabolism; oncology, and respiratory diseases. The Company operates through Healthcare segment. The Company is engaged in the business of manufacturing, distribution and marketing of pharmaceutical products and also provides clinical trial services to an overseas group company. Its therapeutic offerings in CVRM business include heart failure, and chronic kidney disease indications for Forxiga (Dapagliflozin). Its approvals in oncology business include the use of Imfinzi (Durvalumab) in Biliary Tract Carcinoma, and use of Lynparza (Olaparib) in early breast cancer. The Company has a portfolio of oral antidiabetic drugs with presence in two drug classes: SGLT2 inhibitors and DPP4 inhibitors. The Company's DPP4 offering comprises of the brands of Onglyza (Saxagliptin) and Kombiglzye (Saxagliptin/Metformin).

AstraZenca Pharma India Share Price

AstraZeneca Pharma India Limited is an Indian biopharmaceutical company. Its therapeutic areas include cardiovascular, renal and metabolic; oncology and respiratory diseases. The company operates through the healthcare segment. The company manufactures, markets and distributes pharmaceuticals and provides clinical research services to a foreign group company. Its therapeutic offering in the CVRM business includes Forxiga (Dapagliflozin) in heart failure and chronic kidney disease. Its approvals in the oncology business include Imfinz (Durvalumab) for the treatment of bile duct carcinoma and Lynparza (Olaparib) for early breast cancer. The company has a range of oral diabetes medications that fall into two drug classes: SGLT2 inhibitors and DPP4 inhibitors. The company's DPP4 offering consists of the Onglyza (Saxagliptin) and Kombiglzye (Saxagliptin/Metform) brands.

AstraZenca Pharma India FAQs

How to Buy AstraZenca Pharma India Share?

up
To purchase AstraZenca Pharma India shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for AstraZenca Pharma India (ticker symbol: ASTRAZEN) on the trading platform provided by your broker and purchase the shares.

What's AstraZenca Pharma India share price today?

up
The stock price of AstraZenca Pharma India as of 06 Dec 2024 is ₹6,535.05

What is the Market Cap of AstraZenca Pharma India?

up
Market capitalisation represents the total market value of a company's outstanding shares. As of 06 Dec 2024, AstraZenca Pharma India (ticker symbol: ASTRAZEN) has a market capitalisation of approximately ₹1,64,10,00,00,000.00

What is the PE and PB ratio of AstraZenca Pharma India?

up
AstraZenca Pharma India Ltd's price-to-book ratio as of 06 Dec 2024 is 23.06, reflecting the market's valuation compared to its asset value. As of 06 Dec 2024, the trailing twelve months P/E (price-to-earnings) ratio is 101.16, indicating the market values the company at around ₹101.16 for every ₹1 of earnings

What is the 52 Week High and Low of AstraZenca Pharma India Share?

up
AstraZenca Pharma India Ltd (ASTRAZEN) hit its 52-week high at ₹8,673.82, and its 52-week low at ₹4,799.82.
Want to learn and earn in Stocks?
Login/Register
Start Learning